Further studies revealed that erythropoietin protects erythrocytes against oxidative stress [54,55], and the hormone may be useful for the treatment of patients suffering from decompensated autoimmune hemolytic anemia [56]. Here, EPO is linked to autoimmune hemolytic anemia.